IceCure Medical Ltd. (ICCM)

NASDAQ

$1.10

$+0.05

(+4.63%)

Regular Market

IceCure Medical Ltd. (ICCM) Live Price Chart

Last updated: ⁦2026-10-13 18:52:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

IceCure Medical Ltd. (ICCM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.10, with a market capitalisation of $5.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.03 to $26.97. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.10M
Open	$1.11
Day's High	$372.00
Day's Low	$1.03
Previous Close	$1.08
Volume	242.88K
Average Volume	139.93K
P/E Ratio	--
52-Week High	$26.97
52-Week Low	$1.03
Dividend Yield	--
Earnings Date	--

IceCure Medical Ltd. (ICCM) Stock Price Today

IceCure Medical Ltd. (ICCM) is currently trading at $1.10 as of 2026-10-13 18:51:00, up 1.48% ($0.02) from the previous close of $1.08

During today's regular trading session, ICCM has traded between $1.03 and $372.00, with a trading volume of 242.88K shares. The current price is near the lower end of today's range.

IceCure Medical Ltd. (ICCM) 7-Day Stock Price Change

Over the past seven days, IceCure Medical Ltd. (ICCM) moved from $1.57 to $1.10, representing a decline of 30.19% ($0.47).

The stock traded between $1.03 and $1.79 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 271.16 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ICCM 52-Week Price Position

Position in Range: 0.2%

52W Low$1.03

52W High$26.97

ICCM is currently trading at $1.10, placing it 0.2% of the way from its 52-week low of $1.03 to its 52-week high of $26.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is IceCure Medical Ltd. (ICCM)?

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

IceCure Medical Ltd. Information

Employees	66
Exchange	NASDAQ
Company Website	https://www.icecure-medical.com

How to Buy IceCure Medical Ltd. (ICCM) Stock on MEXC

Eligible investors can buy real shares of IceCure Medical Ltd. (ICCM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ICCM and Place Your Order

Open the RealStocks trading page and search for ICCM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is IceCure Medical Ltd. (ICCM) stock price today?

IceCure Medical Ltd. (ICCM) is currently trading at $ 1.10, up 1.48% ($0.02) from the previous close of $ 1.08. Intraday prices update in real time during regular trading hours.

2.Is ICCM stock going up or down today?

As of 2026-10-13 18:51:00, ICCM is trading at $ 1.10, up 1.48% ($0.02) from its previous close of $ 1.08. The stock has traded between $ 1.03 and $ 372.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ICCM pre-market price?

As of 2026-10-13 18:51:00, ICCM is trading at $ 1.11 in pre-market trading, up 2.87% ($0.03) from the previous close of $ 1.08. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ICCM after-hours price?

As of 2026-10-13 18:51:00, ICCM is trading at $ 1.07 in after-hours trading, down 0.93% ($0.01) from the regular-session close of $ 1.08. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ICCM stock trading now?

ICCM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ICCM sit relative to its 52-week high and low?

Over the past 52 weeks, ICCM has traded between a low of $ 1.03 and a high of $ 26.97. At $ 1.10, the stock is positioned 0.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is IceCure Medical Ltd. in?

IceCure Medical Ltd. (ICCM) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is IceCure Medical Ltd.'s market capitalisation and where is it listed?

IceCure Medical Ltd. is listed on the NASDAQ exchange with a market capitalisation of $ 5.10M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ICCM valued in terms of P/E ratio and EPS?

ICCM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does IceCure Medical Ltd. pay a dividend?

IceCure Medical Ltd. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.